Professor Glenn A. Okun
The Rabid Capitalist: The Big Point is a brief summary of a detailed note available to paid subscribers.
BrightSpring closed at $11 on its first day of trading, after going public at $13. It is the latest transaction to disappoint investors in the IPO market. However, the market’s weakness is not limited to large IPOs. These stocks must perform in the secondary market, as measured by price appreciation, in order for IPO market to remain open.
Subscribe to discover how to profit from this news.
Complete content is available for a $15 monthly subscription. Click here to subscribe:
Leave a comment